β-Amyloid (1-15) is a fragment of β-Amyloid peptide. Beta-amyloid is a peptide that forms amyloid plaques in the brains of Alzheimer's disease (AD) patients.
β-Amyloid 1-15 is a synthetic peptide fragment corresponding to the N-terminal residues 1 through 15 of the human amyloid beta (Aβ) protein. As a biochemically defined segment of the larger amyloid precursor protein (APP), this peptide holds significant relevance in neurodegenerative disease research, particularly in studies of Alzheimer's disease pathogenesis. Its sequence encompasses key residues implicated in early aggregation events, antibody recognition, and interactions with cellular components. Due to its defined structure and biological significance, β-Amyloid 1-15 is widely utilized in experimental systems investigating the molecular mechanisms underlying amyloidogenesis, protein-protein interactions, and neurotoxicity.
Antibody Epitope Mapping: Researchers employ β-Amyloid 1-15 as a standard tool for mapping antibody binding sites within the amyloid beta sequence. Its defined N-terminal region allows for precise identification and validation of monoclonal and polyclonal antibody specificities, aiding in the development and characterization of reagents for immunodetection of Aβ species. This application is crucial for distinguishing between different isoforms and truncated variants in both in vitro assays and tissue-based studies.
Neurodegeneration Mechanism Studies: The peptide serves as a model substrate for elucidating the biochemical events associated with amyloidogenic processing. By focusing on the initial residues of the amyloid beta sequence, investigators can dissect early conformational changes, aggregation propensities, and interactions with metal ions or cellular membranes. Such studies provide insights into the molecular triggers of oligomerization and plaque formation, which are central to neurodegenerative disease research.
Peptide-Protein Interaction Analysis: β-Amyloid 1-15 is frequently used to probe interactions between amyloid beta and a range of binding partners, including receptors, enzymes, and chaperone proteins. Its N-terminal sequence is known to mediate specific contacts with cellular components, making it valuable for identifying and characterizing molecular interactions that influence amyloid beta's biological activity. These investigations facilitate a deeper understanding of the pathways modulated by Aβ in neuronal and glial environments.
Analytical Assay Development: The defined sequence and physicochemical properties of β-Amyloid 1-15 make it an ideal standard or control in analytical methodologies such as mass spectrometry, high-performance liquid chromatography (HPLC), and enzyme-linked immunosorbent assays (ELISA). Its use enables accurate quantification, calibration, and validation of detection techniques targeting amyloid beta peptides, thereby supporting the development of robust assays for research and diagnostic applications.
Peptide Synthesis and Modification Studies: As a representative N-terminal amyloid beta fragment, β-Amyloid 1-15 is utilized in synthetic chemistry and peptide engineering workflows. It serves as a template for studying post-translational modifications, such as phosphorylation or acetylation, and for generating labeled or modified analogs. These efforts contribute to the design of specialized probes, the exploration of structure-activity relationships, and the advancement of peptide-based technologies relevant to neurobiology and protein aggregation research.
2. Myotropic activity of allatostatins in tenebrionid beetles
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More